S 2886 New Jersey Senate · 2024-2025 Regular Session

Requires pharmacies to provide certain information regarding insulin manufacturer assistance programs.

This bill requires pharmacies in New Jersey to display a notice and provide a pamphlet about insulin manufacturer assistance programs at all points of sale. The materials must be created by the Department of Banking and Insurance and will be available to anyone purchasing insulin or requesting them. Insulin manufacturers offering assistance programs may request to be included in these materials. The bill directly affects pharmacies (by mandating the notices/pamphlets) and insulin users (by providing access to cost-saving program information). It does not create new programs but ensures existing manufacturer assistance options are clearly communicated to patients.

Issues: ✓ Healthcare

Sub-Topics: Prescription Drugs

Bill status signed all 5 stages cleared

Introduction

Mar 2024

Committee Review

May 2025

Senate Passage

Feb 2025

General Assembly Passage

May 2025

Signed into Law

Jul 2025

Introduced Mar 4, 2024 Signed Jul 8, 2025

Maddy AI version diff · 1 comparison

What changed between versions

Introduced Version → Reprint SCM 2/11/25 1R · 5 edits

MODERATE

The Senate Commerce Committee amended S2886 to shift regulatory authority from the Department of Banking and Insurance to the Department of Health, change the notice requirement from physical display at all points of sale to conspicuous display on the pharmacy's website, clarify that pamphlets are provided only upon request, and double the effective date from six months to twelve months after enactment. These changes reduce the compliance burden on pharmacies and give the implementing department more time to prepare.

SCOPE

Regulatory authority over insulin assistance program notices and pamphlets shifted from the Department of Banking and Insurance to the Department of Health.

REQUIREMENT

The notice requirement changed from displaying a physical notice at all points of sale in the pharmacy to displaying it in a conspicuous manner on the pharmacy's website, significantly reducing the physical compliance burden.

Pamphlet distribution was clarified to occur only 'at the individual's request,' making it explicit that pharmacies are not required to proactively hand out pamphlets.

TIMELINE

The effective date was extended from the first day of the sixth month following enactment to the first day of the twelfth month following enactment, doubling the implementation period.

TECHNICAL

Assemblywoman Tennille R. McCoy and several other legislators were added as co-sponsors.

Floor votes · Senate Feb 25, 2025 · General Assembly May 22, 2025

How they voted

38–0

Passed · 2 other

Total votes 40

Feb 25, 2025

D Democratic25

23 Yea 2

92% Yea

R Republican15

15 Yea

100% Yea

Vote distribution

All Yea All Nay Mixed No data

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Jul 8, 2025

Signed into law

Approved P.L.2025, c.90.

executive

May 22, 2025

Lower · Passed

Passed Assembly (Passed Both Houses) (77-0-0)

lower

May 15, 2025

Lower · Passed

Reported out of Assembly Committee, 2nd Reading

lower

Feb 25, 2025

Committee

Received in the Assembly, Referred to Assembly Financial Institutions and Insurance Committee

lower

Feb 25, 2025

Upper · Passed

Passed Senate (38-0)

upper

Feb 10, 2025

Upper · Passed

Reported out of Senate Committee with Amendments, 2nd Reading

upper

Mar 4, 2024

Introduced

Introduced in the Senate, Referred to Senate Commerce Committee

upper

3 primary · 7 co-sponsors